NGS reagent kit AVENIO

for researchfor DNA extractionfor oncology

AVENIO ctDNA Analysis Kits are a portfolio of three NGS liquid biopsy assays for oncology research. Using a streamlined workflow to evaluate ctDNA extracted from plasma, these assays provide an end-to-end solution for tumor profiling, longitudinal monitoring of tumor burden, and minimal residual disease (MRD) detection. Key Advantages of AVENIO ctDNA Analysis Kits Matched ctDNA and tissue panels (same genes, gene regions and hybrid-capture workflow) to facilitate concordance analysis Includes genes in the U.S. National Comprehensive Cancer Network (NCCN) Guidelines1 All four mutation classes (SNVs, indels, fusions and CNVs) in a single assay Exceptional analytical performance supported by integrated digital error suppression (iDES) strategies combining molecular barcodes with in silico error suppression techniques2,3 Includes reagents for DNA extraction, library preparation and target enrichment, as well as bioinformatics and software required to analyze sequencing data and generate reports Streamlined, end-to-end workflow from extraction to analysis and reporting in five days